Showing results (91-100 of 694) with videos related to
Sort By:
Pageof 70
Developments in Biologicals|April 8, 2003
Adoption of three Rs alternatives for regulatory testing of vaccines in the developing world: possibilities and barriersJ L Di Fabio, M T Jaramillo, J L ArciniegaDevelopments in Biologicals|May 24, 2003
Modelling the immunogenicity of therapeutic proteins using T cell epitope mappingA S De Groot, J Rayner, W MartinDevelopments in Biologicals|May 24, 2003
Bioassays for the measurement of neutralizing antibodies in serum (SNFs)S R IndelicatoDevelopments in Biologicals|May 24, 2003
Animal models as indicators of immunogenicity of therapeutic proteins in humansJ L BussiereDevelopments in Biologicals|May 4, 2000
Properties of cyanovirin-N (CV-N): inactivation of HIV-1 by sessile cyanovirin-N (sCV-N)M J Gandhi, M R Boyd, L Yi, et al.Developments in Biologicals|May 4, 2000
Reducing the risk of bacterial contamination of cellular blood componentsM A BlajchmanDevelopments in Biologicals|February 24, 2001
Improved methods for the quantification of free and linked spacer in conjugate vaccine processO Adam, M MoreauDevelopments in Biologicals|February 24, 2001
Monitoring stability of meningococcal group C conjugate vaccines; correlation of physico-chemical methods and immunogenicity assaysM M Ho, X Lemercinier, B Bolgiano, et al.Developments in Biologicals|February 24, 2001
Structure activity studies on group C meningococcal polysaccharide-protein conjugate vaccines: effect of O-acetylation on the nature of the protective epitopeF Michon, C H Huang, E K Farley, et al.Developments in Biologicals|February 24, 2001
Characterization of a recombinant outer surface protein A (OspA) vaccine against Lyme diseaseR C Huebner, M A Gray, J Holt, et al.Pageof 70